Timothy Storer, MD
Dermatology · Delaware, OHNPI 1376501734
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.8%), consulting fees and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.6%. Reporting peaked in 2024 at $19,273 and has fallen 80.0% since, to $3,847 in 2025. Among dermatology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $78.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dermavant Sciences, Inc.$7K
- E.r. Squibb & Sons, L.L.C.$6K
- Organon$6K
- Sanofi$3K
- AbbVie$2K
- Galderma Laboratories, L.p.$2K
- plus $8K from 21 others
Across 1 payment — averaging $531.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$531
What the payments were for
- Consulting fees$14,79545%
- Grants$2,0066%
- Travel & lodging$7772%
- Food & beverage$15,08046%
- Education$2791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dermavant Sciences, Inc. | 40 | $7,101 |
| E.r. Squibb & Sons, L.L.C. | 15 | $6,164 |
| Organon | 9 | $5,549 |
| Sanofi | 17 | $2,521 |
| AbbVie | 79 | $1,917 |
| Galderma Laboratories, L.p. | 43 | $1,554 |
| Almirall LLC | 6 | $1,307 |
| Pfizer | 62 | $1,223 |
| Journey Medical Corporation | 15 | $1,024 |
| Regeneron Healthcare Solutions, Inc. | 24 | $875 |
| Sun Pharmaceutical Industries Inc. | 24 | $768 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $656 |
| Lilly USA, LLC | 17 | $555 |
| Novartis | 5 | $248 |
| Johnson & Johnson | 5 | $244 |
| Amgen | 13 | $216 |
| Incyte Corporation | 5 | $212 |
| Biofrontera Inc. | 2 | $168 |
| VYNE Pharmaceuticals Inc. | 2 | $149 |
| UCB, Inc. | 2 | $142 |
| Arcutis Biotherapeutics, Inc. | 6 | $102 |
| Boehringer Ingelheim | 5 | $86 |
| Bristol Myers Squibb | 1 | $80 |
| LEO Pharma Inc. | 2 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Sandoz | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,937 in reported general payments places this provider in the 90th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 38 | $349,232 |
| Dupixent PenDupilumab | 52 | $223,976 |
| Skyrizi PenRisankizumab-Rzaa | 11 | $218,908 |
| Clobetasol Propionate | 276 | $11,136 |
| Metronidazole | 66 | $5,701 |
| Acitretin | 11 | $4,324 |
| Doxycycline Hyclate | 72 | $3,642 |
| Fluocinonide | 52 | $2,183 |
| Triamcinolone Acetonide | 364 | $2,146 |
| Ketoconazole | 83 | $1,202 |
| Fluorouracil | 18 | $1,107 |
| Tacrolimus | 13 | $892 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 16 | $805 |
| ValacyclovirValacyclovir Hcl | 34 | $796 |
| Imiquimod | 38 | $784 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Delaware
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
- Dawn MerrittAthens$844K
- Neil KormanCleveland$824K
- Joshua GrosshandlerWesterville$479K
- Lorie GottwaldToledo$460K
- Gregory DelostMayfield Heights$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.